ANKRD26 mutation has been previously associated with myeloid malignancies, including acute myeloid leukemia, myelodysplastic syndrome, and chronic myeloid leukemia. Here, ANKRD26 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.